Lobbying Filing Details

Total Spending

$630,000

Activities

2

Lobbyists

3

Gov't Entities

6

Filing Information
Filing UUID:
88600f70-4cda-4c61-aa37-b3398bf253fb
Type:
Q2 - 2nd Quarter - Report
Period:
2019 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 22, 2019 at 4:17 PM
Income:
$0
Expenses:
$630,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: G. Joel Baise, Director, Government Relations
Registrant
WALGREEN COMPANY

Retail Pharmacy

WASHINGTON, District of Columbia
Client
WALGREEN COMPANY
District of Columbia, United States of America
Lobbying Activities (2)
Activity 1
Consumer Issues/Safety/Products

Issues related to data privacy and HIPAA modernization; no legislation.

Lobbyists (3)
  • ALETHIA JACKSON
  • MR. EDWARD KALETA III
  • KATHARINE TROLLER BOND
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 2
Pharmacy

Amending the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients related to opioid risk factor reduction and opioid antagonist counseling; no legislation.

H.R. 1034 and S.B. 640 (the Phair Pricing Act); provisions related to lowering drug prices and reducing "Out-of-Pocket" costs to seniors.

Lobbyists (3)
  • ALETHIA JACKSON
  • MR. EDWARD KALETA III
  • KATHARINE TROLLER BOND
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.